Effects of Colloid Pre-loading on Thromboelastography during Elective Intracranial Tumor Surgery in Pediatric Patients: Hydroxyethyl Starch 130/0.4 versus 5% Human Albumin

Status

Active, not recruiting

Phases

Phase 4

Study type

Interventional

Source

ChiCTR

Registry ID

ChiCTR-IPR-16009333

Enrollment

Unknown

Registered

2016-10-08

Start date

2011-01-01

Completion date

Unknown

Last updated

2017-04-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

brain tumor

Interventions

HES130/0.4 Group:HES130/0.4

Eligibility

Sex/Gender

Male

Age

1 Years to 12 Years

Inclusion criteria

Inclusion criteria: Pediatric patients aged 1–12 years with American Society of Anesthesiologists physical status III who were scheduled to undergo elective intracranial tumor resection.

Exclusion criteria

Exclusion criteria: known preoperative coagulation disorders, renal diseases or plasma creatinine concentration > 1.5 mg/dL; known liver diseases or increased plasma levels of alanine aminotransferase (>50 U/L) or aspartate aminotransferase (>50 U/L); and taking coumarin anticoagulants, non-steroidal anti-inflammatory agents, acetylsalicylic acid, or colloid management within the previous 2 weeks. Patients with craniopharyngioma and hypothalamic tumors

Design outcomes

Primary

Measure	Time frame
Thromboelastography;	—

Countries

China

Contacts

Public ContactPeng Yuanzhi

Department of Anesthesiology, Xinhua Hospital Affiliated to Shanghai Jiaotong University

baonba1982@aliyun.com+86 15900554407

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026